Acute renal failure in sepsis - media-01.imu.nl
Transcript of Acute renal failure in sepsis - media-01.imu.nl
![Page 1: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/1.jpg)
Acute renal failure in sepsis
Prof. Dr. J.G. van der HoevenRadboud University Nijmegen Medical Centre
![Page 2: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/2.jpg)
Sepsis and mortality
Netherlands 8500 - 9000 cases of severe sepsis/yr
![Page 3: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/3.jpg)
ARF in sepsis
Moderate sepsisN = 649
Severe sepsisN = 467
Septic shockN = 110
Acute renal failure•Positive culture•Negative culture
19%5%
23%16%
51%38%
ARDS•Positive culture•Negative culture
6%3%
8%4%
18%18%
![Page 4: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/4.jpg)
ARF in sepsis
• Mortality 50 - 70%
• Pathophysiology is complex and includes hemodynamic changes and renal inflammation
![Page 5: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/5.jpg)
![Page 6: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/6.jpg)
•Predominant afferent constriction•High risk with NSAID’s, ACEi•Tubular function initially intact
Schrier RW. N Engl J Med 2004;351:159-169
![Page 7: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/7.jpg)
Renal blood flow in human sepsis
PAH-RPF/true RPF (n/n) PAH-RPF (ml/min) True RPF (ml/min)
6 (0)40 (11)22 (6)
-475474
69011161238
True RPF includes renal vein sampling for PAH - normal RPF 600 - 700 ml/min)
![Page 8: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/8.jpg)
Renal blood flow after endotoxin infusion
Plac
ebo
NA
C
Schaller G. Crit Care Med 2007;35:1869-1875
![Page 9: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/9.jpg)
Schrier RW. N Engl J Med 2004;351:159-169
![Page 10: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/10.jpg)
Hypothesis from animal experiments
Sepsis
iNOS ↑
NO ↑eNOS ↓Local
inflammation
Cellular damage Cellular damage
![Page 11: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/11.jpg)
UrineBlood
• Creatinine and urea Clearance
• Cytokines (TNF-α, IL-β)
• C-Reactive Protein
• Leukocytes and trombocytes
• NO metabolites (nitrate, nitrite)
Isolation
Protein RNA
Western blot Real TimePCR
UrineBlood
• Creatinine
•• C-Reactive Protein
•
• NO metabolites (nitrate, nitrite)
Isolation
Protein RNA
Expression iNOS
•••
Creatinine and urea ClearanceGST-α and GST-π (ELISA)NO metabolites (nitrate, nitrite)
Western blot Real TimePCR
![Page 12: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/12.jpg)
White = lowest 10Gray = highest 10
Early renal damage
Eijkenboom JJA. Intensive Care Med 2005;31:664-667
![Page 13: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/13.jpg)
LPS
LPS
Control
LPS + aminoguanidine
Correlation between cumulativeNOx excretion and GST A1
(r = 0.67, p = 0.013)
Heemskerk S. Clin J Am Soc Nephrol (2006), 1: 853-862
![Page 14: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/14.jpg)
Control
LPS
LPS + aminoguanidine
Correlation between cumulative NOx excretion and GST A1 only after LPS (r = 0.67, p = 0.013)
NOx excretion and renal damage
Heemskerk S. Clin J Am Soc Nephrol (2006), 1: 853-862
![Page 15: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/15.jpg)
Human septic shock
Placebo
AP
Heemskerk S. Clin J Am Soc Nephrol 2007 (submitted)
![Page 16: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/16.jpg)
Placebo
Placebo
APAP
Heemskerk S. Clin J Am Soc Nephrol 2007 (submitted)
![Page 17: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/17.jpg)
Heemskerk S. Clin J Am Soc Nephrol 2007 (submitted)
![Page 18: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/18.jpg)
Methylene blue
• Nine patients with norepinephrine refractory septic shock
• Infusion of methylene blue 1 mg/kg/hr for 4 hrs
• 90% decrease in urinary NO metabolites
• Decrease in GST-A1 and GST-P1 of 45 and 70%
• Increase in creatinine clearance of 51%Heemskerk S. Intensive Care Med 2007
![Page 19: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/19.jpg)
Heemskerk S. Intensive Care Med 2007
![Page 20: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/20.jpg)
What does not work?
• Frusemide
• Low dose dopamine
• N-Acetyl Cysteine
![Page 21: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/21.jpg)
Schrier RW. N Engl J Med 2004;351:159-169
? ? ?
?
?
![Page 22: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/22.jpg)
Singer M. Crit Care Med 2007;35:S441-S448
![Page 23: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/23.jpg)
Autoregulation
![Page 24: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/24.jpg)
Optimal MAP in sepsis
MAP 65 MAP 75 MAP 85
Lactate (mmol/l) 3.1 ± 0.9 2.9 ± 0.8 3.0 ± 0.9
Urine (ml/hr) 49 ± 18 56 ± 21 43 ± 13
Capillary blood flow (ml/min/100 gr) 6.0 ± 1.6 5.8 ± 1.2 5.3 ± 0.9
PiCO2 (mm Hg) 41 ± 2 47 ± 2 46 ± 2
Pa-PiCO2 (mm Hg) 13 ± 3 17 ± 3 16 ± 3
LeDoux D. Crit Care Med 2000;28:2729-2732
![Page 25: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/25.jpg)
Optimal MAP in sepsis
0
20
40
60
80
100
120
140
160
65 mm Hg (4 hrs) 65 mm Hg (8 hrs) 65 mm Hg (4 hrs) 85 mm Hg (8 hrs)
Cre
ati
nin
e c
leara
nce
(m
l/m
in)
Bourgoin A. Crit Care Med 2005;33:780-786
![Page 26: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/26.jpg)
Renal Resistive Index
Renal resistive index (PSV-EDV)/PSV
Deruddre S. Intensive Care Med 2007;33:1557-1562
![Page 27: Acute renal failure in sepsis - media-01.imu.nl](https://reader033.fdocuments.in/reader033/viewer/2022052105/6286e99397604026bf3f14f4/html5/thumbnails/27.jpg)
Conclusions
• Local renal iNOS activation and NO production play a possible role in sepsis-induced acute kidney injury
• This opens new possibilities for the prevention and treatment of acute kidney injury
• Second study with alkaline phosfatase recently started